Treatment research after failure of fourth‐line standard therapy for advanced gastrointestinal stromal tumors: A review

Documenti analoghi

• Updates on research and management of gastrointestinal stromal tumors in China
  di: Xinhua Zhang, et al.
  Pubblicazione: (2025)
• Imatinib adherence prediction using machine learning approach in patients with gastrointestinal stromal tumor
  di: Li Liu, et al.
  Pubblicazione: (2024)
• Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial
  di: Jun Zhang, et al.
  Pubblicazione: (2025)
• Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study
  di: Xiangfei Sun, et al.
  Pubblicazione: (2024)
• Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors
  di: Toshirou Nishida, et al.
  Pubblicazione: (2024)